ADAP Crisis Threatens Access to Lifesaving HIV Care

This Quick Take warns that the AIDS Drug Assistance Program (ADAP), a foundational part of the HIV care safety net, is under growing strain. It is a core part of the nation’s HIV care system and a critical last-resort source of access to lifesaving antiretroviral therapy (ART) for many living with HIV. But after years of increasing need for ADAP assistance in the face of flat funding, rising drug costs, Medicaid unwinding, and reduced insurance premium assistance, states are now facing serious budget pressure that threatens access to HIV medications and care. Some states are considering tighter eligibility rules, benefit reductions, or even waiting lists — all ways to deny access to clinically recommended ART to people who need it. Stable access to ART is essential not only for individual health and survival, but also for maintaining viral suppression and preventing new HIV transmissions.

The ADAP crisis requires urgent federal and state action to prevent avoidable harm. Increasing federal and state investment, avoiding cost-containment strategies that cut people off from clinically recommended treatment, simplifying Medicaid enrollment and renewal processes, and using emergency tools to stabilize access to HIV medications is crucial to contain the crises.

---

Citations

1. HIV Drugs Ryan White, N.Y. Times (Mar. 2, 2026)
2. Unwinding, Nat’l Health L. Program
3. NASTAD ADAP Watch: February 2026, NASTAD (Feb. 2026),
4. U=U: The Evidence Is In. Spreading the Word that Undetectable = Untransmittable Is the Next Crucial Step, Infectious Diseases Soc’y of Am. (2021),
5. HIV Deaths from 1999-2020, Ctrs. for Disease Control & Prevention (June 27, 2022)
6. NHSS Surveillance Slideset: Mortality, Ctrs. for Disease Control & Prevention
7. PMC5315764, Nat’l Libr. of Med.
8. HIV Statistics, HIV.gov
9. Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data-United States and 6 Dependent Areas-2013, Ctrs. for Disease Control & Prevention (2014)
10. Clinical Infectious Diseases 60(1):117, Oxford Univ. Press
11. National HIV Prevention and Care Objectives, Ctrs. for Disease Control & Prevention
12. 2025 New Data: Ryan White HIV/AIDS Program, Health Res. & Servs. Admin. (2025)
13. Article DOI 10.1007/s41669-025-00584-0, Springer (2025)
14. HIV/AIDS Management, Fla. Dep’t of Health
15. Florida Guts Its AIDS Drug Assistance Program, Positively Aware
16. Constrained Budgets Lead States to Restrict HIV Drug Access Through Ryan White, KFF
17. Special Enrollment Period for Florida ADAP Consumers, HIV.gov
18. States Are Limiting HIV Drug Assistance Programs, Stateline (Mar. 10, 2026)
19. Waiting for AIDS Medications in the United States: An Analysis of ADAP Waiting Lists, KFF (2013)
20. States Are Limiting HIV Drug Assistance Programs, Stateline (Mar. 10, 2026)
21. Waiting for AIDS Medications in the United States: An Analysis of ADAP Waiting Lists, KFF (2013)
22. States Are Limiting HIV Drug Assistance Programs, Stateline (Mar. 10, 2026)
23. The ADAP Watch, TheBodyPro
24. Fact Sheet: AIDS Drug Assistance Programs, KFF
25. Constrained Budgets Lead States to Restrict HIV Drug Access Through Ryan White, KFF
26. Ending the HIV Epidemic Initiative Overview, HIV.gov
27. 2026 National Ryan White HIV/AIDS Program Part B ADAP Monitoring Project Annual Report, NASTAD (2026)